\
&
Contact us
\
&
Contact us
This was 2 weeks ago
LocationBrussels or online
The European Institute for Innovation and Technology (EIT) has recently launched a call to join the new knowledge and innovation community (KIC) on water. A KIC is a community where the three sides of the so-called "Knowledge Triangle" (education, research and innovation achieved by industry) come together in order to create succesful innovative businesses and upskill the workforce of the future.
To inform all interested parties about this call, the EIT organises an online information session on the 5th of March. This is part of the European Ocean Days 2025, organised by the European Commission’s Directorate-General for Maritime Affairs and Fisheries (DG MARE).
If you want to follow it online you do not need to register and the streaming link will be published on this website. However if you want to be present in person you need to register here. There is only one participant per organisation allowed so it is best to register as soon as possible. The deadline for registration is the 28th of February.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
